Concepedia

Kimio Terao

KT

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

1994

Affiliations

Chugai Pharma (United States)(Current)

National Cancer Center Hospital East

National Center of Neurology and Psychiatry

Kimio Terao is an author at Chugai Pharma (United States) specializing in medicine, immunology, and neuroimmunology.

Top concepts

Publications per year

1994–2023

10

Publications

10

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

Norihiro Nishimoto, Kimio Terao, Toru Mima et al. · Blood · 2008 · 791 citations · Full text

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels

Tomofumi Miura, Shuichi Mitsunaga, Masafumi Ikeda et al. · Pancreas · 2015 · 84 citations

Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab

Tomomi Tsuru, Kimio Terao, Miho Murakami et al. · Modern Rheumatology · 2013 · 64 citations

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects

Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama et al. · Drug Research · 2017 · 39 citations

Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)

Shuji Ohta, Tomomi Tsuru, Kimio Terao et al. · The Journal of Clinical Pharmacology · 2013 · 30 citations · Full text

1–5 of 10